Learn more

AERAS GLOBAL TB VACCINE FOUND

Overview
  • Total Patents
    80
  • GoodIP Patent Rank
    190,597
About

AERAS GLOBAL TB VACCINE FOUND has a total of 80 patent applications. Its first patent ever was published in 2005. It filed its patents most often in WIPO (World Intellectual Property Organization), China and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are AGRICULTURAL TECHNOLOGY RES INST, LECLERC DENIS and IMNATE SARL.

Patent filings per year

Chart showing AERAS GLOBAL TB VACCINE FOUNDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Sadoff Jerald C 59
#2 Hone David Michael 31
#3 Sun Ronggai 25
#4 Fulkerson John 22
#5 Stone Michele 14
#6 Onyabe David 9
#7 Michael Hone David 8
#8 Shafferman Avigdor 7
#9 Zvi Anat 7
#10 Anantha Ravi P 6

Latest patents

Publication Filing date Title
JP2018134074A Recombinant mycobacterium encoding heparin binding hemagglutinin (hbha) fusion protein and uses thereof
EP3013364A1 Tuberculosis compositions and methods of using the same
EP2838990A1 Recombinant mycobacterium encoding a heparin-binding hemagglutinin (hbha) fusion protein and uses thereof
US2011117133A1 Recombinant BCG tuberculosis vaccine designed to elicit immune responses to mycobacterium tuberculosis in all physiological stages of infection and disease
WO2010025016A2 Enhancement of transgene expression from virus-based vaccine vectors using suppressors of the type 1 interferon response
CN102089423A Enhancement of transgene expression from viral-based vaccine vecors by expression of suppressors of the type i interferon response
US2009136534A1 Recombinant BCG tuberculosis vaccine designed to elicit immune responses to Mycobacterium tuberculosis in all physiological stages of infection and disease
US2009068222A1 Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response
US2008286852A1 Electroporation of Mycobacterium and overexpression of antigens in mycobacteria
WO2007079351A2 Novel prime-boost combinations of attenuated mycobacterium
WO2007038420A2 Process for stabilization of bacterial cells
WO2006132966A2 Webbed hiv envelope immunogens, methods for production and use of same
CA2587507A1 Electroporation of mycobacterium and overexpression of antigens in mycobacteria
WO2007050099A2 Recombinant bcg strains with attenuated immunosuppresive properties
ZA200704766B Bacterial packaging strains useful for generation and production of recombinant double-stranded RNA nucleocapsids and uses thereof